Blog

Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for

Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on July 17, 2025 to

Today, the Board of Directors of WaFd, Inc. (Nasdaq: WAFD) (the “Company”), announced a regular quarterly cash dividend of 27 cents per share. The dividend will be paid June 6, 2025, to common

Orbia Advance Corporation, S.A.B. de C.V. (“Orbia”) (BMV: ORBIA*), announces that today it has completed the successful issuance and placement of its 6.800% and 7.500% Senior Notes due 2030 and

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the first quarter ending March 31, 2025 and

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ending March 31, 2025. For the first quarter of 2025, sales were $2.5 billion, flat on a

Regulatory News:

The Combined General Meeting of shareholders of GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and

Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, IoT systems and cloud connectivity service provider, announced plans to release the financial results of its first quarter of

Helmerich & Payne, Inc. (NYSE: HP) today announced that Mike Lennox, Senior Vice President of Americas Operations, Dave Wilson, Vice President of Investor Relations, and other members of the

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious neurological and

PROS Holdings, Inc. (NYSE: PRO), a leading provider of AI-powered SaaS pricing and selling solutions, today announced the winners of its second annual 2025 Customer Outperformer Awards. The awards

Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI) dedicated to serving the company’s institutional clients, announced today that veteran commercial real estate

Regulatory News:

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies^TM (MET) dedicated to

Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be

More than half of enterprises say AI governance is a major concern that, if not addressed, could limit the deployment and potential value of large language models (LLMs) through 2027, according to

Manhattan Associates Inc. (NASDAQ: MANH), a global leader in supply chain commerce solutions, today announced the retirements of John J. Huntz, Jr., and Deepak Raghavan from its Board of Directors

Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, has added the Ping An of China CSI HK Dividend ETF to its growing lineup of ETFs. This ETF is available through

Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to business, government, healthcare, and education markets, is pleased to announce that it has

AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) today announced a new contract with the Dutch Ministry of Defence (MoD) to modernize the Netherlands’ Puma™ UAS fleet with expanded capabilities for

WisdomTree, Inc. (NYSE: WT), a global financial innovator, today announced it has expanded its global footprint through a strategic collaboration with Korea Investment Management Co., Ltd. (KIM) in

GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison™ (Perflutren Protein-Type A Microspheres

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Bank of America 2025 Health Care Conference on Wednesday, May 14^th, at 8:40 a.m. PT (11:40

UiPath (NYSE: PATH), a global leader in agentic automation, today announced that it has been named a Leader in ​​the IDC MarketScape: Worldwide Business Automation Platforms 2025 Vendor Assessment​

NICE (Nasdaq: NICE) today announced a new strategic collaboration agreement (SCA) with Amazon Web Services (AWS), to transform how businesses deliver customer service through tightly integrated AI